KLF9 and metastatic neoplasm: More strikingly, the expression of KLF9 was further downregulated in the patients who developed intrahepatic metastasis at diagnosis compared to patients who did not have metastatic diseases (Figure 6C), further suggesting an antimetastasis role of KLF9 in liver cancer.